PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for tough liver disease
Disease control TerminatedThis study tested whether combining two drugs, obeticholic acid and bezafibrate, could better control Primary Biliary Cholangitis (PBC), a chronic liver disease. It was for patients whose standard treatment wasn't working well or who couldn't tolerate it. The main goal was to see…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Trial tests Long-Term safety of promising liver disease drug duo
Disease control TerminatedThis study aimed to check the long-term safety and side effects of a fixed-dose pill combining two drugs, obeticholic acid and bezafibrate, for people with primary biliary cholangitis (PBC), a chronic liver disease. It was an open-label extension study for 63 participants who had…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC